Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

777
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
777
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

564
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
564
Decision Making01:20

Decision Making

789
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
789

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research Code Sharing in Support of Gold Standard Science.

Journal of diabetes science and technology·2026
Same author

Identifying and Intervening on Glucose Patterns in Multivariate Data Using Block-Based Recurrence Quantification Analysis.

Journal of diabetes science and technology·2025
Same author

Artificial intelligence in metabolic research.

Nature metabolism·2025
Same author

Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study.

Diabetes care·2025
Same author

Metabolic Models, in Silico Trials, and Algorithms.

Journal of diabetes science and technology·2025
Same author

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.

Journal of diabetes science and technology·2025

Related Experiment Video

Updated: Dec 18, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Artificial Intelligence in Decision Support Systems for Type 1 Diabetes.

Nichole S Tyler1, Peter G Jacobs1

  • 1Artificial Intelligence for Medical Systems Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.

Sensors (Basel, Switzerland)
|June 11, 2020
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) decision support systems offer personalized recommendations for managing type 1 diabetes (T1D). These systems help optimize insulin doses and predict/avoid hypoglycemia, improving glucose control.

Keywords:
Artificial Intelligencedecision supportinsulin advisortype 1 diabetes

More Related Videos

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.1K
Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
05:49

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization

Published on: February 23, 2024

1.2K

Related Experiment Videos

Last Updated: Dec 18, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.1K
Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
05:49

Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization

Published on: February 23, 2024

1.2K

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) management requires frequent insulin adjustments, often delayed by provider consultations.
  • Manual insulin delivery methods (pumps, injections) necessitate careful glucose monitoring and titration.
  • Automated decision support systems (AI-DS) are emerging to personalize T1D management.

Purpose of the Study:

  • To comprehensively review computational and AI-based decision support systems for T1D management.
  • To categorize AI-DS based on their function: insulin adjustment or hypoglycemia prediction/prevention.
  • To analyze the AI methods, performance, and applications of these T1D management systems.

Main Methods:

  • Systematic literature search across PubMed, IEEE Xplore, and ScienceDirect databases.
  • Review of 61 selected articles based on algorithm evaluation using real-world data, in silico trials, or clinical studies.
  • Categorization of AI-DS into insulin adjustment and hypoglycemia management systems.

Main Results:

  • Identified AI-DS that recommend insulin dose adjustments for improved glucose control.
  • Reviewed AI-DS designed to predict and help avoid hypoglycemic events.
  • Discussed various AI methodologies employed in these T1D decision support systems.

Conclusions:

  • AI-based decision support systems show significant potential for personalized T1D management.
  • These systems can aid in optimizing insulin delivery and preventing hypoglycemia.
  • Further research and clinical validation are crucial for widespread adoption of AI-DS in T1D care.